NYSE:USNA - USANA Health Sciences Stock Price, Forecast & News

USANA Health Sciences trades on the New York Stock Exchange (NYSE) under the ticker symbol "USNA."

USANA Health Sciences declared that its Board of Directors has authorized a stock buyback program on Wednesday, February 5th 2020, which allows the company to buyback $130,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to purchase up to 9.1% of its stock through open market purchases. Stock buyback programs are generally an indication that the company's board of directors believes its shares are undervalued.

USANA Health Sciences, Inc. (NYSE:USNA) released its earnings results on Tuesday, February, 4th. The company reported $1.41 EPS for the quarter, topping the consensus estimate of $0.98 by $0.43. The company had revenue of $271.30 million for the quarter, compared to analysts' expectations of $256.46 million. USANA Health Sciences had a net margin of 9.48% and a return on equity of 27.90%. The business's quarterly revenue was down 9.3% compared to the same quarter last year. During the same period last year, the company earned $1.32 EPS. View USANA Health Sciences' Earnings History.

USANA Health Sciences is scheduled to release their next quarterly earnings announcement on Tuesday, May 5th 2020. View Earnings Estimates for USANA Health Sciences.

USANA Health Sciences issued an update on its FY20 earnings guidance on Tuesday, February, 4th. The company provided earnings per share (EPS) guidance of $4.10-$4.90 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.38. The company issued revenue guidance of $1.03-$1.13 billion, compared to the consensus revenue estimate of $1.06 billion.

4 brokers have issued 1-year target prices for USANA Health Sciences' shares. Their forecasts range from $65.00 to $75.00. On average, they anticipate USANA Health Sciences' stock price to reach $70.00 in the next year. This suggests that the stock has a possible downside of 2.2%. View Analyst Price Targets for USANA Health Sciences.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for USANA Health Sciences in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for USANA Health Sciences.

Media stories about USNA stock have been trending very negative recently, InfoTrie reports. The research firm rates the sentiment of press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. USANA Health Sciences earned a media sentiment score of -3.4 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for USANA Health Sciences.

Some companies that are related to USANA Health Sciences include Estee Lauder Companies (EL), Herbalife Nutrition (HLF), Avon Products (AVP), Inter Parfums (IPAR), Prestige Consumer Healthcare (PBH), Nu Skin Enterprises (NUS), Medifast (MED), Revlon (REV), Veru (VERU) and Nature's Sunshine Products (NATR).

Based on aggregate information from My MarketBeat watchlists, some companies that other USANA Health Sciences investors own include Allergan (AGN), Gilead Sciences (GILD), IBM (IBM), AbbVie (ABBV), Amgen (AMGN), Intel (INTC), Ionis Pharmaceuticals (IONS), Abbott Laboratories (ABT), Novartis (NVS) and Biogen (BIIB).

USANA Health Sciences' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (7.51%), Acadian Asset Management LLC (3.49%), State Street Corp (1.84%), Man Group plc (0.81%), Bank of New York Mellon Corp (0.72%) and Russell Investments Group Ltd. (0.68%). Company insiders that own USANA Health Sciences stock include Brent Neidig, Daniel A Macuga, David Mulham Mulham, Feng Peng, Frederic J Winssinger, G Doug Iiekking, Gilbert A Fuller, Global Ltd Gull, Jim Brown, Joshua Foukas, Kevin Guest, Myron W Wentz, Paul A Jones, Robert A Sinnott, Robert Auciaux and Walter Noot. View Institutional Ownership Trends for USANA Health Sciences.

USNA stock was sold by a variety of institutional investors in the last quarter, including Schroder Investment Management Group, MERIAN GLOBAL INVESTORS UK Ltd, MERIAN GLOBAL INVESTORS UK Ltd, AQR Capital Management LLC, Robeco Institutional Asset Management B.V., Renaissance Technologies LLC, Bank of America Corp DE and Panagora Asset Management Inc.. Company insiders that have sold USANA Health Sciences company stock in the last year include Brent Neidig, G Doug Iiekking, Gilbert A Fuller, Jim Brown, Joshua Foukas, Kevin Guest, Robert Auciaux and Walter Noot. View Insider Buying and Selling for USANA Health Sciences.

USNA stock was purchased by a variety of institutional investors in the last quarter, including Jacobs Levy Equity Management Inc., Skandinaviska Enskilda Banken AB publ , TD Asset Management Inc., California Public Employees Retirement System, Russell Investments Group Ltd., Man Group plc, Great West Life Assurance Co. Can and Vident Investment Advisory LLC. Company insiders that have bought USANA Health Sciences stock in the last two years include Global Ltd Gull and Myron W Wentz. View Insider Buying and Selling for USANA Health Sciences.

Shares of USNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of USNA stock can currently be purchased for approximately $71.54.

USANA Health Sciences has a market capitalization of $1.55 billion and generates $1.06 billion in revenue each year. The company earns $100.53 million in net income (profit) each year or $4.41 on an earnings per share basis. USANA Health Sciences employs 1,911 workers across the globe.View Additional Information About USANA Health Sciences.

The official website for USANA Health Sciences is http://www.usana.com/.

USANA Health Sciences' mailing address is 3838 West Parkway Blvd, Salt Lake City UT, 84120. The company can be reached via phone at 801-954-7100 or via email at [email protected]